KMRtype® / KMRtrack®

Comprehensive solution for chimerism study by qPCR, combining pre-transplant genetic typing kits and post-transplant quantitative monitoring.

Detailed Description

KMRtype® and KMRtrack® are complementary systems developed by GenDx for the characterization and monitoring of chimerism in transplant patients, using qPCR-based assays. The system allows everything from the identification of unique informative markers between recipient and donor, to the precise quantification of reference DNA in post-transplant samples.

KMRtype and KMRtrack KMRtype and KMRtrack Analysis

KMRtype® is a genetic typing kit that allows the selection of informative markers between recipient and donor DNA. Each mix contains three multiplexed primers and is used in pre-transplant settings. The kits are available in Core (30 assays in 10 mixes) and Extended (15 assays in 5 additional mixes) versions, allowing coverage of up to 45 assays in total. This phase is essential to identify which specific markers can be used effectively for monitoring.

KMRtrack and KMRengine

KMRtrack® is used for post-transplant monitoring using singleplex qPCR assays. Each marker selected in the typing phase is used to quantify the proportion of reference DNA (either from the recipient or the donor) in the samples, allowing precise monitoring of the patient’s chimeric status over time. The achieved limit of detection is 0.05%, depending on the amount of DNA used.

Both kits are optimized for use alongside the KMRengine® software, which guides experimental setup, manages qPCR plates, analyzes results, and automatically reports the chimerism percentage. The platform allows registering multiple samples, designing customized experiments, and visualizing data graphically and chronologically.

Performance and Validation

Validation studies showed 100% accuracy in typing and high intra- and inter-batch reproducibility in monitoring. Specificity was confirmed for all markers. Detection tests indicated that the system maintains robust performance with variable amounts of DNA, making it ideal for both clinical and experimental samples.

Important Considerations

Use with non-human DNA or cfDNA is not recommended. The use of at least two informative markers is recommended to avoid false results. Reagents are light-sensitive and must be stored at -20 °C. Heparinized samples should not be used, as they interfere with PCR. It is necessary to physically separate pre- and post-PCR areas to avoid cross-contamination.

Clinical Applications

This system is indicated for chimerism studies in the context of hematopoietic stem cell transplantation, with special utility in graft monitoring and early detection of relapse. Its sensitivity allows the detection of minimal amounts of donor or recipient-derived DNA, facilitating early therapeutic decisions.

Key Features

Complete system for chimerism typing and monitoring using qPCR.
Identification of specific informative markers for each donor-recipient pair.
Chimerism detection with sensitivity down to 0.05%.
Optimized protocols for genomic DNA from blood.
Automated analysis with KMRengine® software.
High inter-batch reproducibility and accuracy.
Compatible with multiple validated qPCR systems.

Ordering Information

KMRtype® RUO & CE-IVD: Core Mixes (30 assays, 24 samples) – Ref. 8341161 / Extended Mixes (15 assays, 24 samples) – Ref. 8341561 KMRtrack® RUO & CE-IVD: Core and Extended Kits, 48 reactions per assay – Ref. 8344162 and 8344562 KMRassay: Reference Assay (REF901) and Buffer & Enzyme – 288 reactions – Ref. 8343264 and 8343263 Versions also available as CE-IVD (see specific references in the IFU) For use with KMRengine® software (included in the GenDx platform) Store at -20 °C, protected from light

Area:

Bone marrow (chimerism), Immunology, Post transplantation

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Sepsis Pathogenic Microorganism Detection Kit (Digital PCR)

In vitro diagnostic kit based on droplet digital PCR (dPCR) for the detection of pathogenic microorganisms associated with sepsis from DNA extracted from clinical samples. The kit allows identification and quantification of pathogens without requiring blood culture, covering 21 frequent agents in bloodstream infections. Detailed Description Principle of operation The Sepsis Pathogenic Microorganism Detection Kit…
RainSure
Digital PCR

VIASURE 16S V1-V4 NGS Solution

NGS solution for library preparation aimed at the simultaneous identification and profiling of microbial species present in DNA extracted from original samples, through the analysis of the variable regions V1-V4 of the 16S rRNA gene. Product for research use only (RUO) and not intended for diagnostic procedures. Detailed Description Principle of operation VIASURE 16S V1-V4…
Certest
Next Generation Sequencing (NGS)

PN-900 CandidaGenius® C. auris screening assay

Real‑time PCR assay for the rapid and direct detection of Candida auris from non‑invasive swabs, without the need for prior culture. Detailed Description The PN-900 CandidaGenius® C. auris screening assay is a molecular tool designed for the qualitative detection of Candida auris DNA by real‑time PCR. This emerging fungus represents a growing challenge in the…
Pathonostics
Real Time PCR (qPCR)

Illumina Viral Surveillance Panel v2

Next‑generation sequencing (NGS) assay with hybrid capture enrichment for the detection and whole‑genome sequencing of approximately 200 RNA and DNA viruses relevant to public health. It integrates library preparation, enrichment, sequencing, and data analysis into an optimized workflow of about two days. Detailed Description Principle of operation The panel can start from RNA, DNA, or…
Illumina
Next Generation Sequencing (NGS)